The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biopharmaceutical Third Party Transportation Services Market Research Report 2025

Global Biopharmaceutical Third Party Transportation Services Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2002880

No of Pages : 93

Ask Your Query
Synopsis
The global market for Biopharmaceutical Third Party Transportation Services was valued at US$ 8000 million in the year 2024 and is projected to reach a revised size of US$ 14060 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Biopharmaceutical third party transportation services refer to transportation services provided by professional logistics companies for biopharmaceutical enterprises, covering the entire logistics solution from production to distribution. This type of services typically include cold chain transportation, warehouse management, and value-added services (such as packaging, labeling, temperature monitoring, etc.) aimed at ensuring the safety, stability, and compliance of biopharmaceutical products (such as vaccines, biologics, gene therapy drugs, etc.) during transportation.
Biopharmaceutical third party transportation services are an indispensable part of the biopharmaceutical industry chain, and the market size has been continuously growing in recent years. With the development of the biopharmaceutical industry, the complexity of biopharmaceutical products and high requirements for transportation conditions have driven the demand for third-party logistics services. The support policies of governments around the world for the biopharmaceutical industry, such as the green logistics requirements under the "carbon neutrality" goal, have promoted the standardized development of the market. The advancement of cold chain technology, temperature control monitoring systems, intelligent logistics platforms, and other technologies has improved transportation efficiency and safety. North America holds a dominant market position due to its mature biopharmaceutical industry and innovative research and development capabilities. The main participants in the global market include Kuehne+Nagel, DHL, DB Schenker, and others. The main enterprises in the Chinese market include Sinopharm Group, SF Express, Kerry Logistics, etc. These enterprises enhance their competitiveness through technological innovation, diversified services (such as providing one-stop logistics solutions), and global layout. In the future, biopharmaceutical third-party logistics companies will pay more attention to reducing carbon emissions and adopting clean energy and energy-saving technologies. The application of artificial intelligence, big data, and IoT technology will further enhance logistics efficiency and service quality. With the intensification of market competition, it is expected that there will be more mergers and acquisitions and collaborations to optimize resource allocation and expand market share.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Third Party Transportation Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Third Party Transportation Services.
The Biopharmaceutical Third Party Transportation Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical Third Party Transportation Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Third Party Transportation Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kuehne+Nagel
DHL
AmerisourceBergen
McKesson
Ryder
Panalpina
Cegelec
UPS
TQL
C.H. Robinson
Perry Group
DB Schenker
Cardinal Health
FedEx
XPO Logistics
Sinopharm Group
Huaxin Supply Chain
SF Express
Kerry Logistics
Shanghai Pharma
Segment by Type
Air Transport
Sea Transportation
Land Transportation
Segment by Application
Vaccine Transportation
Blood Products Transportation
Cell And Gene Therapy Products Transportation
Clinical Trial Drug Transportation
Drug Distribution And Retail
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Third Party Transportation Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Air Transport
1.2.3 Sea Transportation
1.2.4 Land Transportation
1.3 Market by Application
1.3.1 Global Biopharmaceutical Third Party Transportation Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Vaccine Transportation
1.3.3 Blood Products Transportation
1.3.4 Cell And Gene Therapy Products Transportation
1.3.5 Clinical Trial Drug Transportation
1.3.6 Drug Distribution And Retail
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Third Party Transportation Services Market Perspective (2020-2031)
2.2 Global Biopharmaceutical Third Party Transportation Services Growth Trends by Region
2.2.1 Global Biopharmaceutical Third Party Transportation Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical Third Party Transportation Services Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical Third Party Transportation Services Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical Third Party Transportation Services Market Dynamics
2.3.1 Biopharmaceutical Third Party Transportation Services Industry Trends
2.3.2 Biopharmaceutical Third Party Transportation Services Market Drivers
2.3.3 Biopharmaceutical Third Party Transportation Services Market Challenges
2.3.4 Biopharmaceutical Third Party Transportation Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Third Party Transportation Services Players by Revenue
3.1.1 Global Top Biopharmaceutical Third Party Transportation Services Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical Third Party Transportation Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Biopharmaceutical Third Party Transportation Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical Third Party Transportation Services Revenue
3.4 Global Biopharmaceutical Third Party Transportation Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical Third Party Transportation Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Third Party Transportation Services Revenue in 2024
3.5 Global Key Players of Biopharmaceutical Third Party Transportation Services Head office and Area Served
3.6 Global Key Players of Biopharmaceutical Third Party Transportation Services, Product and Application
3.7 Global Key Players of Biopharmaceutical Third Party Transportation Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Third Party Transportation Services Breakdown Data by Type
4.1 Global Biopharmaceutical Third Party Transportation Services Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical Third Party Transportation Services Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical Third Party Transportation Services Breakdown Data by Application
5.1 Global Biopharmaceutical Third Party Transportation Services Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical Third Party Transportation Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical Third Party Transportation Services Market Size (2020-2031)
6.2 North America Biopharmaceutical Third Party Transportation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical Third Party Transportation Services Market Size (2020-2031)
7.2 Europe Biopharmaceutical Third Party Transportation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Third Party Transportation Services Market Size (2020-2031)
9.2 Latin America Biopharmaceutical Third Party Transportation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kuehne+Nagel
11.1.1 Kuehne+Nagel Company Details
11.1.2 Kuehne+Nagel Business Overview
11.1.3 Kuehne+Nagel Biopharmaceutical Third Party Transportation Services Introduction
11.1.4 Kuehne+Nagel Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.1.5 Kuehne+Nagel Recent Development
11.2 DHL
11.2.1 DHL Company Details
11.2.2 DHL Business Overview
11.2.3 DHL Biopharmaceutical Third Party Transportation Services Introduction
11.2.4 DHL Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.2.5 DHL Recent Development
11.3 AmerisourceBergen
11.3.1 AmerisourceBergen Company Details
11.3.2 AmerisourceBergen Business Overview
11.3.3 AmerisourceBergen Biopharmaceutical Third Party Transportation Services Introduction
11.3.4 AmerisourceBergen Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.3.5 AmerisourceBergen Recent Development
11.4 McKesson
11.4.1 McKesson Company Details
11.4.2 McKesson Business Overview
11.4.3 McKesson Biopharmaceutical Third Party Transportation Services Introduction
11.4.4 McKesson Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.4.5 McKesson Recent Development
11.5 Ryder
11.5.1 Ryder Company Details
11.5.2 Ryder Business Overview
11.5.3 Ryder Biopharmaceutical Third Party Transportation Services Introduction
11.5.4 Ryder Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.5.5 Ryder Recent Development
11.6 Panalpina
11.6.1 Panalpina Company Details
11.6.2 Panalpina Business Overview
11.6.3 Panalpina Biopharmaceutical Third Party Transportation Services Introduction
11.6.4 Panalpina Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.6.5 Panalpina Recent Development
11.7 Cegelec
11.7.1 Cegelec Company Details
11.7.2 Cegelec Business Overview
11.7.3 Cegelec Biopharmaceutical Third Party Transportation Services Introduction
11.7.4 Cegelec Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.7.5 Cegelec Recent Development
11.8 UPS
11.8.1 UPS Company Details
11.8.2 UPS Business Overview
11.8.3 UPS Biopharmaceutical Third Party Transportation Services Introduction
11.8.4 UPS Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.8.5 UPS Recent Development
11.9 TQL
11.9.1 TQL Company Details
11.9.2 TQL Business Overview
11.9.3 TQL Biopharmaceutical Third Party Transportation Services Introduction
11.9.4 TQL Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.9.5 TQL Recent Development
11.10 C.H. Robinson
11.10.1 C.H. Robinson Company Details
11.10.2 C.H. Robinson Business Overview
11.10.3 C.H. Robinson Biopharmaceutical Third Party Transportation Services Introduction
11.10.4 C.H. Robinson Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.10.5 C.H. Robinson Recent Development
11.11 Perry Group
11.11.1 Perry Group Company Details
11.11.2 Perry Group Business Overview
11.11.3 Perry Group Biopharmaceutical Third Party Transportation Services Introduction
11.11.4 Perry Group Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.11.5 Perry Group Recent Development
11.12 DB Schenker
11.12.1 DB Schenker Company Details
11.12.2 DB Schenker Business Overview
11.12.3 DB Schenker Biopharmaceutical Third Party Transportation Services Introduction
11.12.4 DB Schenker Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.12.5 DB Schenker Recent Development
11.13 Cardinal Health
11.13.1 Cardinal Health Company Details
11.13.2 Cardinal Health Business Overview
11.13.3 Cardinal Health Biopharmaceutical Third Party Transportation Services Introduction
11.13.4 Cardinal Health Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.13.5 Cardinal Health Recent Development
11.14 FedEx
11.14.1 FedEx Company Details
11.14.2 FedEx Business Overview
11.14.3 FedEx Biopharmaceutical Third Party Transportation Services Introduction
11.14.4 FedEx Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.14.5 FedEx Recent Development
11.15 XPO Logistics
11.15.1 XPO Logistics Company Details
11.15.2 XPO Logistics Business Overview
11.15.3 XPO Logistics Biopharmaceutical Third Party Transportation Services Introduction
11.15.4 XPO Logistics Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.15.5 XPO Logistics Recent Development
11.16 Sinopharm Group
11.16.1 Sinopharm Group Company Details
11.16.2 Sinopharm Group Business Overview
11.16.3 Sinopharm Group Biopharmaceutical Third Party Transportation Services Introduction
11.16.4 Sinopharm Group Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.16.5 Sinopharm Group Recent Development
11.17 Huaxin Supply Chain
11.17.1 Huaxin Supply Chain Company Details
11.17.2 Huaxin Supply Chain Business Overview
11.17.3 Huaxin Supply Chain Biopharmaceutical Third Party Transportation Services Introduction
11.17.4 Huaxin Supply Chain Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.17.5 Huaxin Supply Chain Recent Development
11.18 SF Express
11.18.1 SF Express Company Details
11.18.2 SF Express Business Overview
11.18.3 SF Express Biopharmaceutical Third Party Transportation Services Introduction
11.18.4 SF Express Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.18.5 SF Express Recent Development
11.19 Kerry Logistics
11.19.1 Kerry Logistics Company Details
11.19.2 Kerry Logistics Business Overview
11.19.3 Kerry Logistics Biopharmaceutical Third Party Transportation Services Introduction
11.19.4 Kerry Logistics Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.19.5 Kerry Logistics Recent Development
11.20 Shanghai Pharma
11.20.1 Shanghai Pharma Company Details
11.20.2 Shanghai Pharma Business Overview
11.20.3 Shanghai Pharma Biopharmaceutical Third Party Transportation Services Introduction
11.20.4 Shanghai Pharma Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
11.20.5 Shanghai Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Air Transport
Table 3. Key Players of Sea Transportation
Table 4. Key Players of Land Transportation
Table 5. Global Biopharmaceutical Third Party Transportation Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biopharmaceutical Third Party Transportation Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biopharmaceutical Third Party Transportation Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Biopharmaceutical Third Party Transportation Services Market Share by Region (2020-2025)
Table 9. Global Biopharmaceutical Third Party Transportation Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Biopharmaceutical Third Party Transportation Services Market Share by Region (2026-2031)
Table 11. Biopharmaceutical Third Party Transportation Services Market Trends
Table 12. Biopharmaceutical Third Party Transportation Services Market Drivers
Table 13. Biopharmaceutical Third Party Transportation Services Market Challenges
Table 14. Biopharmaceutical Third Party Transportation Services Market Restraints
Table 15. Global Biopharmaceutical Third Party Transportation Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Biopharmaceutical Third Party Transportation Services Market Share by Players (2020-2025)
Table 17. Global Top Biopharmaceutical Third Party Transportation Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Third Party Transportation Services as of 2024)
Table 18. Ranking of Global Top Biopharmaceutical Third Party Transportation Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical Third Party Transportation Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Biopharmaceutical Third Party Transportation Services, Headquarters and Area Served
Table 21. Global Key Players of Biopharmaceutical Third Party Transportation Services, Product and Application
Table 22. Global Key Players of Biopharmaceutical Third Party Transportation Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical Third Party Transportation Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Biopharmaceutical Third Party Transportation Services Revenue Market Share by Type (2020-2025)
Table 26. Global Biopharmaceutical Third Party Transportation Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Biopharmaceutical Third Party Transportation Services Revenue Market Share by Type (2026-2031)
Table 28. Global Biopharmaceutical Third Party Transportation Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Biopharmaceutical Third Party Transportation Services Revenue Market Share by Application (2020-2025)
Table 30. Global Biopharmaceutical Third Party Transportation Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Biopharmaceutical Third Party Transportation Services Revenue Market Share by Application (2026-2031)
Table 32. North America Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. Kuehne+Nagel Company Details
Table 48. Kuehne+Nagel Business Overview
Table 49. Kuehne+Nagel Biopharmaceutical Third Party Transportation Services Product
Table 50. Kuehne+Nagel Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 51. Kuehne+Nagel Recent Development
Table 52. DHL Company Details
Table 53. DHL Business Overview
Table 54. DHL Biopharmaceutical Third Party Transportation Services Product
Table 55. DHL Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 56. DHL Recent Development
Table 57. AmerisourceBergen Company Details
Table 58. AmerisourceBergen Business Overview
Table 59. AmerisourceBergen Biopharmaceutical Third Party Transportation Services Product
Table 60. AmerisourceBergen Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 61. AmerisourceBergen Recent Development
Table 62. McKesson Company Details
Table 63. McKesson Business Overview
Table 64. McKesson Biopharmaceutical Third Party Transportation Services Product
Table 65. McKesson Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 66. McKesson Recent Development
Table 67. Ryder Company Details
Table 68. Ryder Business Overview
Table 69. Ryder Biopharmaceutical Third Party Transportation Services Product
Table 70. Ryder Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 71. Ryder Recent Development
Table 72. Panalpina Company Details
Table 73. Panalpina Business Overview
Table 74. Panalpina Biopharmaceutical Third Party Transportation Services Product
Table 75. Panalpina Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 76. Panalpina Recent Development
Table 77. Cegelec Company Details
Table 78. Cegelec Business Overview
Table 79. Cegelec Biopharmaceutical Third Party Transportation Services Product
Table 80. Cegelec Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 81. Cegelec Recent Development
Table 82. UPS Company Details
Table 83. UPS Business Overview
Table 84. UPS Biopharmaceutical Third Party Transportation Services Product
Table 85. UPS Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 86. UPS Recent Development
Table 87. TQL Company Details
Table 88. TQL Business Overview
Table 89. TQL Biopharmaceutical Third Party Transportation Services Product
Table 90. TQL Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 91. TQL Recent Development
Table 92. C.H. Robinson Company Details
Table 93. C.H. Robinson Business Overview
Table 94. C.H. Robinson Biopharmaceutical Third Party Transportation Services Product
Table 95. C.H. Robinson Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 96. C.H. Robinson Recent Development
Table 97. Perry Group Company Details
Table 98. Perry Group Business Overview
Table 99. Perry Group Biopharmaceutical Third Party Transportation Services Product
Table 100. Perry Group Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 101. Perry Group Recent Development
Table 102. DB Schenker Company Details
Table 103. DB Schenker Business Overview
Table 104. DB Schenker Biopharmaceutical Third Party Transportation Services Product
Table 105. DB Schenker Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 106. DB Schenker Recent Development
Table 107. Cardinal Health Company Details
Table 108. Cardinal Health Business Overview
Table 109. Cardinal Health Biopharmaceutical Third Party Transportation Services Product
Table 110. Cardinal Health Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 111. Cardinal Health Recent Development
Table 112. FedEx Company Details
Table 113. FedEx Business Overview
Table 114. FedEx Biopharmaceutical Third Party Transportation Services Product
Table 115. FedEx Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 116. FedEx Recent Development
Table 117. XPO Logistics Company Details
Table 118. XPO Logistics Business Overview
Table 119. XPO Logistics Biopharmaceutical Third Party Transportation Services Product
Table 120. XPO Logistics Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 121. XPO Logistics Recent Development
Table 122. Sinopharm Group Company Details
Table 123. Sinopharm Group Business Overview
Table 124. Sinopharm Group Biopharmaceutical Third Party Transportation Services Product
Table 125. Sinopharm Group Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 126. Sinopharm Group Recent Development
Table 127. Huaxin Supply Chain Company Details
Table 128. Huaxin Supply Chain Business Overview
Table 129. Huaxin Supply Chain Biopharmaceutical Third Party Transportation Services Product
Table 130. Huaxin Supply Chain Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 131. Huaxin Supply Chain Recent Development
Table 132. SF Express Company Details
Table 133. SF Express Business Overview
Table 134. SF Express Biopharmaceutical Third Party Transportation Services Product
Table 135. SF Express Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 136. SF Express Recent Development
Table 137. Kerry Logistics Company Details
Table 138. Kerry Logistics Business Overview
Table 139. Kerry Logistics Biopharmaceutical Third Party Transportation Services Product
Table 140. Kerry Logistics Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 141. Kerry Logistics Recent Development
Table 142. Shanghai Pharma Company Details
Table 143. Shanghai Pharma Business Overview
Table 144. Shanghai Pharma Biopharmaceutical Third Party Transportation Services Product
Table 145. Shanghai Pharma Revenue in Biopharmaceutical Third Party Transportation Services Business (2020-2025) & (US$ Million)
Table 146. Shanghai Pharma Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report


List of Figures
Figure 1. Biopharmaceutical Third Party Transportation Services Picture
Figure 2. Global Biopharmaceutical Third Party Transportation Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharmaceutical Third Party Transportation Services Market Share by Type: 2024 VS 2031
Figure 4. Air Transport Features
Figure 5. Sea Transportation Features
Figure 6. Land Transportation Features
Figure 7. Global Biopharmaceutical Third Party Transportation Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Biopharmaceutical Third Party Transportation Services Market Share by Application: 2024 VS 2031
Figure 9. Vaccine Transportation Case Studies
Figure 10. Blood Products Transportation Case Studies
Figure 11. Cell And Gene Therapy Products Transportation Case Studies
Figure 12. Clinical Trial Drug Transportation Case Studies
Figure 13. Drug Distribution And Retail Case Studies
Figure 14. Biopharmaceutical Third Party Transportation Services Report Years Considered
Figure 15. Global Biopharmaceutical Third Party Transportation Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Biopharmaceutical Third Party Transportation Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Biopharmaceutical Third Party Transportation Services Market Share by Region: 2024 VS 2031
Figure 18. Global Biopharmaceutical Third Party Transportation Services Market Share by Players in 2024
Figure 19. Global Biopharmaceutical Third Party Transportation Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Biopharmaceutical Third Party Transportation Services Revenue in 2024
Figure 21. North America Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Biopharmaceutical Third Party Transportation Services Market Share by Country (2020-2031)
Figure 23. United States Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biopharmaceutical Third Party Transportation Services Market Share by Country (2020-2031)
Figure 27. Germany Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biopharmaceutical Third Party Transportation Services Market Share by Region (2020-2031)
Figure 35. China Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biopharmaceutical Third Party Transportation Services Market Share by Country (2020-2031)
Figure 43. Mexico Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Share by Country (2020-2031)
Figure 47. Turkey Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Biopharmaceutical Third Party Transportation Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Kuehne+Nagel Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 51. DHL Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 52. AmerisourceBergen Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 53. McKesson Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 54. Ryder Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 55. Panalpina Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 56. Cegelec Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 57. UPS Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 58. TQL Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 59. C.H. Robinson Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 60. Perry Group Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 61. DB Schenker Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 62. Cardinal Health Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 63. FedEx Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 64. XPO Logistics Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 65. Sinopharm Group Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 66. Huaxin Supply Chain Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 67. SF Express Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 68. Kerry Logistics Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 69. Shanghai Pharma Revenue Growth Rate in Biopharmaceutical Third Party Transportation Services Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock